Johns Hopkins Malaria Research Institute | Johns Hopkins Bloomberg School of Public Health

Founded in May 2001 and continuously supported by Bloomberg Philanthropies, the Johns Hopkins Malaria Research Institute conducts discovery research at the Bloomberg School of Public Health in Baltimore and field research at the Macha Research Trust in Zambia and other sites of endemic malaria in sub-Saharan Africa, India, and elsewhere.

The initial Bloomberg Philanthropies gift established a state-of-the-art research facility with the goal to treat and control malaria, develop a vaccine, and find new drug targets and innovative strategies to prevent and cure the deadly disease. The Institute has contributed to advances in all these areas and is one of the most comprehensive research endeavors focused on malaria globally.

Join us!

9th Future of Malaria Research Symposium

Attend the 9th Future of Malaria Research Symposium on Friday, October 13, at the BSPH. This complimentary, hybrid symposium is organized by students and postdocs, providing a platform for early-career scientists to share research. Submit abstracts by September 8th to present short talks, lightning talks, or posters.

Click Here To Register

News and Noteworthy

Jane Carlton, PhD

Leading Researcher Jane Carlton Joins Bloomberg School of Public Health’s Johns Hopkins Malaria Research Institute as Director. She assumed the role on August 1. A leader in the field of comparative genomics, the goal of Jane Carlton's research is to find and improve ways to monitor and control malaria, as well as to identify ways to prevent and treat the mosquito-borne disease.

Gene editing could eliminate mosquitoes, but is it a good idea?

Conor McMeniman is quoted in a CNN article on gene editing: “New technology that could help to specifically and efficiently control this plague on humanity is welcomed, but I would caution that we need to carefully test this and also engage communities at risk to see what their attitudes are.”

CNN